Assessment of Efficacy and Optimization of Antiplatelet Therapy in Patients with Ischemic Heart Disease

Authors

  • Mirzayeva G. P. Tashkent medical academy
  • Jabbarov O. O. Tashkent medical academy
  • Umarova Z. F. Tashkent medical academy
  • Qodirova Sh. I. Tashkent medical academy
  • Tursunova L. D. Tashkent medical academy
  • Nadirova Yu. I. Tashkent medical academy
  • Rahmatov A. M. Tashkent medical academy

Keywords:

Ischemic heart disease, acetylsalicylic acid, antiplatelet therapy

Abstract

The review article presents the problems of inadequate disaggregant response to deaggregant therapy. So far no reliable information about the frequency and causes of these complications. Cardiovascular diseases stably hold the leading position among the causes of death in the world. Today, as we know, 50% of all deaths in developed countries are caused by coronary heart disease (CHD).

It requires astronomical sums to maintain social health population both in terms of improving the quality of life and its extension. It is the great social significance of the problem and its economic side is the main engines of progress in coronary surgery.

Downloads

Published

2023-03-10

Issue

Vol. 2 No. 3 (2023): MARCH

Section

Articles